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Abstract 
The objective of this study was to contribute to investigate the efficacy of letrozole, a 
potent non-steroidal aromatase inhibitor, on serum sex steroid levels and oocyte growth 
in rainbow trout females. Serum steroid levels were measured using an indirect 
enzyme-linked immunosorbent assay (ELISA) before and 22 days after an initial 
injection with 1, 2.5 mg kg-1 and subsequent weekly injection with 2.5 mg kg-1letrozole. 
After the last blood collection, gonad tissues were removed and oocyte diameter and 
GSI were determined. In all groups treated with letrozole, serum 17β- esteradiol levels 
(E2) decreased significantly and inversely serum 17α-20ß dihydroxy-4 pregnen- 3- one 
(17α-20ß-P), testosterone(T) levels increased significantly from 6 to 96 h after injection 
(p<0.05). The lowest E2 levels, oocyte diameter and GSI were measured in the group 
treated weekly with 2.5 mg kg-1 letrozole (p<0.05). This study demonstrates that 
letrozole has the potential to interfere in the synthesis of endogenous estrogens from 
androgens and delay gonadal development.  
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Introduction
The gonads in teleost fishes are 
stimulated by gonadotropic (GTH), 
follicle stimulating (FSH) and 
luteinizing (LH) hormones to produce 
steroid hormones and germ cell (Yaron 
et al., 2003; Amini et al., 2012). Some 
androgens, as testosterone (T), can be 
aromatized to estrogens (Afonso et al., 
2000; Ankley et al., 2002). Aromatase 
is a member of the P450 cytochrome 
super family of enzymes that catalyzes 
the formation of estrogen from 
androgen. Estrogens, particularly 17β- 
estradiol (E2), are sex steroids 
implicated in many crucial processes in 
vertebrates, including development, 
growth and reproduction (Haynes et al., 
2003; Sun et al., 2007). As such, the 
first clinical aromatase inhibitor, 
aminoglutethimide, was developed for 
the treatment of advanced breast cancer 
around 25 years ago (Howell and 
Buzdar, 2005). Recently non- steroidal 
competitive inhibitors letrozole and 
anastrozole are many times more 
specific and potent than 
aminoglutethimide (Seralini and 
Moslemi, 2001; Haynes et al., 2003). 
The potential of Aromatase inhibitors 
(AIs) for blocking estrogen biosynthesis 
has been demonstrated in both invivo 
and invitro studies on mammals 
(Selvaraj et al., 1994; Bajetta et al., 
2000). Letrozole (CGS 20267) is one of 
the most potent aromatase inhibitors yet 
developed (Smith, 1999). 
      It has potential for use both to 
prevent the conversion of androgenic 
steroids to estrogens and to prevent or 
diminish the side effects of androgenic 
steroid abuse (Haynes et al., 2003). 
Aromatase inhibitors can enter aquatic 
systems and cause ecotoxicological 
effects. The effects of aromatase 
inhibitors have been shown in 
aquaculture to sex differentiation and 
reproduction of fish (Piferrer et al., 
1994; Afonso et al., 1999,2000; Ankley 
et al., 2002; LI et al., 2005). 
     The high activity of aromatase in 
teleost suggests that aromatase enzyme 
constitutes a potential target for 
endocrine disrupting chemicals (EDCS) 
(Hinfray et al., 2006). Association 
between decreased brain aromatase 
activity, circulating E2 levels and 
ovarian somatic index in females of 
perch (Perca fluviatilis) was reported 
(Noaksson et al., 2001). Also the 
effects of letrozole on reproductive 
fitness and early life stages of Japanese 
medaka (Oryzia latipes) have been 
reported by Sun et al. (2007). They 
showed that inhibition of aromatase in 
fish could result in significant adverse 
effects on endocrine function and 
reproduction (Sun et al., 2007).  
      In rainbow trout, morphological and 
physiological changes occur during 
growth to sexual maturity, and sexual 
maturation (gonadal maturity and 
reproductive activities) can potentially 
affect both the innate and adaptive 
immune responses (Slater and Schreck, 
1993; Suzuki et al., 1997;  Harris and 
Bird, 2000). Therefore the development 
of techniques, which could retard 
sexual maturation in fishes are 
important. The objective of this study 
was to evaluate the effects of letrozole, 
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on serum sex steroid secretion and 
gonadal development in females of 
rainbow trout. 
 
Materials and methods 
Forty eight female rainbow trout fishes 
(O. mykiss) with an average weight of 
854 g, were obtained from a coldwater 
fish farm (Shiraz, Iran) in mid-
September 2011. A seven day 
acclimation period preceded the 
exposure period. During acclimation, 
the fish were maintained outdoors in a 
10 m2 concrete pond supplied with 
through- flowing river water. The fish 
were kept in well- aerated water (pH 
7.2-7.8, dissolved oxygen 5.5-6 ppm) at 
a constant temperature (15.8-16°C). 
Then the fishes were randomly divided 
into experimental groups and each 
group was in a 2 m2 concrete pond 
supplied with through- flowing river. 
During the experiment, the fish were 
fed with commercial salmon food 
(Beyza Feed Mill (BFM) Co., Ltd., 
Iran). The non- steroidal aromatase 
inhibitor Letrozole (CGS 20267) [1, 2, 
6,73H]-4- Androstron-3,17- dione, was 
obtained as a gift from Iran hormone 
venture pharmaceutical technology 
development Co., Ltd. Iran, dissolved 
in the vehicle ethanol (Shilling et al., 
1999). Stock solutions which contained 
1.0, 2.5 mg of AI ml-1 were prepared. 
The fish were anesthetized (150 ppm 
clove oil), then injected 
intraperitonially with letrozole. Fishes 
were divided in four groups, (1) Control 
group injected with the vehicle ethanol 
only (1.0 ml kg-1body weight (n=12), 
(2) group injected once with 1.0 mg kg-1 
letrozole (n=12), (3) group injected 
once with 2.5 mg kg-1 letrozole (n=12) 
and (4) group injected  weekly with 2.5 
mg AI kg-1 letrozole (3×2.5 mg AI kg-1) 
(n=12).  
 
Sampling 
Blood samples (3ml) were taken and 
collected from the caudal vein at 0 h 
(just before injection with letrozole), 6, 
24, 48, 96, 144,192, 288,384,482,528 h 
after injection with letrozole. Serum 
samples were collected from six fishes 
of each group. The serum was aliquoted 
into 1.5 ml plastic tubes and frozen on 
dry ice and stored at -20°C until assay 
(Salamat et al., 2012). After the last 
blood collection, three fish of each 
group, were dissected and ovaries were 
excised and weighted in order to 
determine the gonado-somatic index 
[GSI=100× (gonad weight / total body 
weight)] and oocyte diameter (Afonso 
et al. , 1999). 
 
Steroid ELISAs 
For steroid analysis, serum samples first 
extracted with alcohol ice-cold 
methanol was added to the serum (6:1 
v/v), shaken and centrifuged (3000g, 15 
min, 4°C). The pellet was re-extracted 
twice with 200 µl of methanol. 
Supernatants were pooled, dried and 
reconstituted in 120 µl of potassium 
phosphate buffer (0.1 M, pH 7.4), then 
stored at -20°C for analysis. Serum E2, 
17α-20ß-P and T levels were measured 
by Enzyme linked immunosorbent 
assays (ELISA) described by Navas and 
Segner (2000) and Guzmán, et al 
(2008) with slight modification. In the 
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steroid ELISA, the microtiter plate 
provided in this kit has been pre coated 
with a goat-anti- rabbit antibody 
(Cusabio Biotech Co.,Ltd). 50 µl 
standards or samples were added to the 
appropriate microtiter plate wells with a 
HRP-conjugated (E2, T,17α-20ß-p) and 
antibody preparation specific for steroid 
and incubated. Then substrate solutions 
were added to each well. The enzyme- 
substrate reaction was terminated by the 
addition of a sulphuric acid solution 
(H2SO4) and the color change was 
measured spectrophotometrically at a 
wavelength of 450 nm± 2nm. The 
concentration of steroid in the samples 
was then determined by comparing the 
O.D of the samples to the standard 
curve. All samples were placed in 
triplicate on the plates. Data were 
expressed as ng ml-1 for serum steroid 
levels (Navas and Segner, 2000; 
Guzmán et al. , 2008). 
 
Statistical analysis 
Normality of variance was tested by the 
Kolmogorov-Smirnov and all data were 
shown as mean ±standard error (SEM). 
One-way ANOVA were used to detect 
variation among experimental groups. 
Group dependent variation in serum 
concentrations for each hormone were 
detected by analysis of variance 
(ANOVA) followed by all pairwise 
multiple comparison by Duncan test 
(Sokal and Rohlf, 1969). Time-
dependent variation within each group 
were studied by repeated measures 
analysis of variance (General linear 
Model) followed by a Student-
Newman-Keuls test, and were 
considered significantly at p<0.05. 
Statistical analysis was conducted using 
SPSS software version 16.0. 
 
Results 
In the control group injected with the 
ethanol vehicle, serum E2 levels 528 h 
after injection increased (2.12±0.08 ng 
ml-1) significantly in relation to the first 
blood collection (p<0.05). In the group 
treated with 1mg kg-1 letrozole, 
decreased significantly from 6 h to 96 h 
after injection, after 96h, rebounded 
significantly (p<0.05) (Table 1). In the 
group injected with 2.5 mg kg-1 
letrozole, from 6h to 96h after injection, 
decreased significantly (p<0.05). But 
serum E2 levels didn't show significant 
difference from 24 h to 96h (p>0.05). 
After 96 h, serum E2 levels increased 
significantly (p<0.05) up to 528 h after 
injection. At 528 h after injection, 
serum E2 levels were similar to the 
levels observed before injection (Table 
1) (p>0.05). In the group injected 
weekly with 2.5 mg kg-1 letrozole, 
declined significantly between 0 and 6 
h and between 6 and 24 h (p<0.05), and 
remained low throughout the 
experimental period (0.07±0 ng ml-1). 
      At 6 h after injection, the groups 
injected with letrozole showed 
significantly (p<0.05) lower serum E2 
levels than the control group (p<0.05), 
but there were not significantly 
different among the groups injected 
with letrozole at the same time 
(p>0.05). At 192 h, serum E2 levels in 
the group injected weekly with 2.5 mg 
kg-1 letrozole were significantly lower 
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(p<0.05) than the other groups (Table 
1). 
 
Table 1: Serum 17ß-estradiol level in pre-spawning female rainbow trout injected or not with  
               Letrozole (mg AI kg-1).  
Each value represents the mean ± standard error. Serum 17ß-esradiol (E2) levels which are similar 
(p>0.05) within each group are identified by the same letter before slash. Serum 17ß-esradiol (E2) levels 
which are similar (p>0.05) among the groups are identified by the same letter before slash. n= number of 
fish in each group. C= control .The ♦, ■, ▲and× indicate the different treatments 
 
In the control group, serum 17α-20β-P 
levels did not show significant 
difference (p>0.05) between 0 h up to 
480 h (Table 2). But 524 h after 
injection with vehicle (1 ml kg-1 
ethanol), serum 17α- 20β-P levels 
(2.15±0.24 ng ml-1) increased 
significantly (p<0.05). 6h after 
injection, serum 17α- 20β-P levels 
increased significantly in the group 
injected with 1 mg kg-1 letrozole, then 
declined significantly from 96h to 480h 
(p<0.05). At 192 and 384 h after 
injection, serum 17α-20β-P levels were 
similar to the levels observed before 
injection (p>0.05). In the group treated 
with 2.5 mg kg-1 letrozole, increased 
significantly (p<0.05) at 6 h after 
injection, but there was not significant 
differences between 24 and 48h 
(p>0.05). From 144 h to 480 h after 
injection, serum 17α-20β-P levels 
declined significantly (p<0.05). But 
17α-20β-P levels at 480 and 288 h were 
similar to which observed before 
injection (p>0.05). In the group injected 
weekly with 2.5 mg kg-1 letrozole, 
increased significantly from 6 h to 96 h 
(p<0.05). At 528 h, serum 17α-20β-P 
levels were higher than the levels 
observed at 0 h (Table 2).  
     At 6 h after injection, in the groups 
injected with Letrozole, 17α-20β-P 
levels were higher than the control 
group injected with ethanol vehicle 
(p<0.05). In the group injected weekly 
with letrozole, 17α-20β-P levels were 
higher than those the other groups 
(p<0.05) at 192 h after injection 
(2.60±0.04 ng ml-1). 
 
 
 
 
 
  17ß-esradiol (ng ml-1) hours after injection Treatment 
528 480 384 288 192 144 96 48 24 6 0  
2.12 
± 
0.08 d 
1.82 
± 
0.10c 
1.61 
± 
0.15bc 
1.15 
± 
0.02a/b 
1.06 
± 
0.02a 
1.09 
± 
0.03a 
1.08 
± 
0.04 a/c 
1.06 
± 
0.04a/c 
1.09 
± 
0.04a/c 
0.92 
± 
0.04a/b 
1.48 
± 
0.15b/a 
C 
n=6 
♦ 
1.84 
± 
0.04d 
1.74 
± 
0.12d 
1.43 
± 
0.10c 
1.16 
± 
0.04c/b 
1.19 
± 
0.05bc 
1.04 
± 
0.03b 
0.50 
± 
0.03a/b 
0.43 
± 
0.03a/b 
0.36 
± 
0.04a/b 
0.60 
± 
0.04a/a 
1.39 
± 
0.17c/a 
1.0 
n=6 
■ 
1.59 
± 
0.03d 
1.13 
± 
0.06c 
1.16 
± 
0.06c 
1.09 
± 
0.02c/b 
1.08 
± 
0.03c 
1.06 
± 
0.05c 
0.20 
± 
0.02a/a 
0.13 
± 
0.01a/a 
0.23 
± 
0.02a/a 
0.48 
± 
0.03b/a 
1.58 
± 
0.19d/a 
2.5 
n=6 
▲ 
0.07 
± 
0a 
0.45 
± 
0.02c 
0.13 
± 
0ab 
0.32 
± 
0.03bc/a 
0.04 
± 
0.01 a 
1.04 
± 
0.06d 
0.23 
± 
0.02ab/a 
0.12 
± 
0ab/a 
0.19 
± 
0.02ab/a 
0.49 
± 
0.04c/a 
1.44 
± 
0.15c/a 
2.5×3 
n=6 
× 
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Table 2: Serum 17α-20ß-P level in pre-spawning female rainbow trout injected or not with  
               Letrozole (mg AI kg-1). 
Each value represents the mean ± standard error. Serum 17α-20ß-P levels which are similar (p>0.05) 
within each group are identified by the same letter before slash. Serum 17α-20ß-P levels which are 
similar (p>0.05) among the groups are identified by the same letter before slash. n=number of fish in 
each group. C= control. The symbols ♦, ■, ▲and× indicate the different treatments. 
 
In the control group, serum testosterone 
levels increased significantly (p<0.05) 
at 48 h after injection (2.60± 0.04 ng 
ml-1). Up to 528 h after injection, 
increased significantly (p<0.05). There 
was no significant difference (p>0.05) 
between 192 and 288 h after injection 
(Table 3). In the group injected with 1 
mg kg-1 letrozole, testosterone levels 
were similar to the levels observed 
before injection (p>0.05). At 48h after 
injection, increased significantly 
(p<0.05) whereas E2 levels decreased 
significantly (p<0.05), and declined 
significantly from 144h to 528h after 
injection (p<0.05). In the group injected 
with 2.5 mg kg-1 letrozole, increased 
significantly from 6h up to 96 h after 
injection (p<0.05). From 144h to 528h 
declined significantly (p<0.05) when 
compared with 96 h after injection. But 
up to 528h, serum testosterone levels 
were higher than the levels observed at 
0 h to 24 h after injection (p<0.05). In 
the group injected weekly with 2.5 mg 
kg-1 letrozole, increased significantly 
from 28 h up to 96 h, and serum 
testosterone levels declined 
significantly from 144 h up to 288 h 
after injection (p<0.05).  
     In the groups injected with letrozole, 
serum testosterone levels increased 
significantly (p<0.05) at 24h after 
injection when compared with the 
control group (Table 3). Comparison 
among the groups showed that the 
group injected weekly indicated 
significantly (p<0.05) lower serum 
testosterone levels than the other three 
groups at 528h (2.77±0.12 ng ml-1). 
 
 
 
 
 
 
 
 
 
  17α-20ß-P (ng ml-1)/ hours after injection Treatment 
528 480 384 288 192 144 96 48 24 6 0  
2.15 
± 
0.24 b 
0.16 
± 
0.05a/a 
0.23 
± 
0.01a/a 
0.18 
± 
0.06a 
0.25 
± 
0.06a/a 
0.17 
± 
0.03a/a 
0.10 
± 
0.04 a 
0.31 
± 
0.04a/a 
0.27 
± 
0.03a/a 
0.20 
± 
0.04a 
0.29 
± 
0.03a/a  
C 
n=6 
♦ 
1.52 
± 
0.05e 
0.39 
± 
0.03b/c 
0.33 
± 
0.04a/b 
0.58 
± 
0.03b 
0.38 
± 
0.03a/a 
0.57 
± 
0.04b/b 
0.91 
± 
0.04c 
1.69 
± 
0.08f/b 
0.6 
± 
0.08b/b 
1.16 
± 
0.06d 
0.21 
± 
0.04a/a 
1.0 
n=6 
■ 
2.14 
± 
0.09c 
0.27 
± 
0.03a/ bc 
0.48 
± 
0.05ab/c 
0.30 
± 
0.03a 
0.36 
± 
0.02c/a 
0.69 
± 
0.07b/b 
3.47 
± 
0.11c 
2.34 
± 
0.07c/c 
2.36 
± 
0.07c/c 
3.19 
± 
0.19d 
0.26 
± 
0.02a/a 
2.5 
n=6 
▲ 
2.89 
± 
0.05de 
2.57 
± 
0.04cd/d 
2.65 
± 
0.04cd/d 
3.15 
± 
0.17e 
2.60 
± 
0.04cd/b 
0.66 
± 
0.06b/b 
3.56 
± 
0.12f 
2.33 
± 
0.06c/c 
2.29 
± 
0.05c/c 
3.08 
± 
0.19c 
0.25 
± 
0.01a/a 
2.5×3 
n=6 
× 
Iranian Journal of Fisheries Sciences 14(1) 2015                                         295 
 
 
 
Table 3: Serum testosterone level in pre-spawning female rainbow trout injected or not with  
               Letrozole (mg AI kg-1).  
Each value represents the mean ± standard error. Serum testosterone levels which are similar (p>0.05) 
within each group are identified by the same letter before slash. Serum testosterone levels which are 
similar (p>0.05) among the groups are identified by the same letter before slash. n= number of fish in 
each group. C= control . The symbols ♦, ■, ▲and× indicate the different treatments 
 
In this paper, the injection procedure of 
letrozole was started in mid- September 
2011 while all females were in 
prepubertal stage (2 months before 
spawning). At the end of the 
experiment, gonads were weighed 
(three fish per group) and oocyte 
diameter and gonadosomatic index 
were checked to evaluate the oocyte 
maturation. The oocyte diameter and 
GSI in all groups except the group 
received multiple injection of 2.5 mg 
kg-1 letrozole (3× 2.5) showed that 
during the 22 days trial period, there 
were a change in the developmental 
stages of the oocytes when compared 
with the developmental stage of the 
oocytes of the fish examined and killed 
at the beginning of the experiment 
(Fig.1). Oocyte diameter in the group 
injected weekly was similar to the 
group examined and killed at the 
beginning of the experiment (p>0.05). 
      The group injected weekly with 2.5 
mg kg-1 letrozole had significantly 
lower (p<0.05) GSI (6.95±0.06%) in 
comparison with the other groups 
(p<0.05). There was a significant 
increase in the GSI during the 
experimental period in all groups 
except the group injected weekly (Fig. 
2). There were no significant 
differences (p>0.05) between the group 
injected with ethanol and the groups 
received a single injection of letrozole 
(p>0.05)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  testosterone (ng ml-1)/ hours after injection Treatment 
528 480 384 288 192 144 96 48 24 6 0  
6.81 
± 
0.08i/c 
6.07 
± 
0.16h/c 
5.73 
± 
0.07g/c 
4.96 
± 
0.0.19f/b 
4.47 
± 
0.10f/c 
3.54 
± 
0.06e/c 
3.04 
± 
0.11d 
2.60 
± 
0.04c/a 
1.60 
± 
0.03a/a 
1.80 
± 
0.07ab 
2.01 
± 
0.07b  
C 
n=6 
♦ 
3.57 
± 
0.05c/b 
3.47 
± 
0.04c/a 
3.39 
± 
0.07bc/a 
3.40 
± 
0.09bc/a 
3.29 
± 
0.05bc/a 
2.97 
± 
0.04b/a 
3.17 
± 
0.04bc 
2.64 
± 
0.06c/b 
2.61 
± 
0.06a/b 
3.39 
± 
0.24bc 
3.18 
± 
0.19bc 
1.0 
n=6 
■ 
3.68 
± 
0.06d/b 
3.81 
± 
0.07d/a 
3.53 
± 
0.07d/a 
3.63 
± 
0.06d/a 
3.67 
± 
0.07d/b 
3.24 
± 
0.06c/b 
4.87 
± 
0.18f 
4.46 
± 
0.04e/c 
2.92 
± 
0.05b/c 
2.15 
± 
0.01a 
2.22 
± 
0.03a 
2.5 
n=6 
▲ 
2.77 
± 
0.12b/a 
4.80 
± 
0.14f/b 
5.47 
± 
0.11g/b 
3.69 
± 
0.27d/a 
3.41 
± 
0.16cd/ ab 
3.25 
± 
0.04cd/b 
5.24 
± 
0.18g 
4.42 
± 
0.07e/c 
2.96 
± 
0.04bc/c 
2.11 
± 
0.04a 
2.29 
± 
0.04a 
2.5×3 
n=6 
× 
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Figure 1: Effects of Letrozole on the oocyte 
diameter from pre- spawning female 
rainbow trout.Each bar represents the 
mean±SEM from females each treatment 
group.Oocyte diameters which are similar 
(p>0.05), as determined by Duncan’s test 
among groups (C=control, LET1=1 mg 
Letrozole kg-1, LET2.5= 2.5 mg Letrozole      
kg-1 and LET 3×2.5= 2.5 mg Letrozole            
kg-1 weekly) are identified by the same 
superscript letter. Number of fish used in 
each group is three. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Effects of Letrozole on the  
gonadosomatic index(GSI) from pre- 
spawning female rainbow trout. Each bar 
represents the mean± SEM from females 
each treatment group.GSI which are similar 
(p>0.05), as determined by Duncan’s test 
among groups (C= control, LET1= 1 mg 
Letrozole kg-1, LET2.5= 2.5 mg Letrozole  
kg-1 and LET 3×2.5= 2.5 mg Letrozole        
kg-1 weekly) are identified by the same 
superscript letter. Number of fish used in 
each group is three. Gonadosomatic index= 
ovary weight /body weight ×100.  
 
Discussion 
In several teleosts, reduced growth and 
lower flesh quality coincides with 
sexual maturation and precocious 
maturation is a problem in commercial 
fish farming (Razmi et al., 2011). 
Therefore, reliable methods to control 
the onset of puberty are required 
(Afonso et al., 1999). Different 
strategies have been developed in order 
to circumvent this drawback (Lee et al., 
2004). Our aim of studying the effects 
of letrozole was to assess an approach 
as a possible method of controlling 
oocyte maturation by a sharp decrease 
in aromatase activity in rainbow trout. 
Starting injection of the aromatase 
inhibitors may be imported on their 
efficiency in blocking pubertal 
maturation (Afonso et al., 1999; Ankley 
et al., 2002). 
      In our study the basal E2 levels were 
twice as high in non-injected females 
compared to injected females from 24 h 
to 96 h after injection with letrozole, 
and serum E2 levels were significantly 
lower in females injected weekly with 
2.5 mg kg-1letrozole. This suggests that 
letrozole, a non-steroidal inhibitor, 
inhibits armatase which catalyzes the 
conversion of androgens, 
androstendione and testosterone via 
three hydroxylation steps to estrone and 
estradiol (Sun et al., 2007). Similar 
results were obtained by Kelloff et al. 
(1998) that a dose responsive increase 
in blood serum steroid was observed in 
trout injected with 50 mg Fadrozole kg-1 
per day. Shilling et al (1999) used 
letrozole (CGS20267) and 
aminoglotethimide (AG) as non-steroid 
and examined in vitro for activity in 
trout ovarian microsomes. They showed 
that letrozole reduced aromatase 
activity a maximum of 90% in dose-
dependent manner. But letrozole and 
clorimazole fed to juvenile rainbow 
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trout at doses up to 1000 ppm for 2 
weeks were not effective in suppressing 
17 β- estradiol levels (Shilling et al., 
1999). Our in vivo data showed that the 
mechanism and efficiency of inhibition 
of letrozole are different. Afonso et al. 
(1999) provided the first evidence that 
injection of the fadrozole was effective 
in vivo in lowering plasma E2 levels, 
and demonstrated a shift from E2 to 
17α-20β-P biosynthesis in fadrozole 
injected female coho salmon (O. 
kisutch). In the adult female rat, 
letrozole (0.3-1mg kg-1 daily) 
completely interrupted ovarian and 
reduced uterine weight and serum 
estradiol (E2) concentration (Bhatnagar 
et al., 1990, 1993; Schieweck et al., 
1993). Sun et al. (2007) showed that the 
application of letrozole for 21 days 
affected the reproductive, gonadal 
development and vitellogenin 
production of Japanese medaka 
(Oryzias latipes) females 
     It took a 4×concentrated (10 mg AI 
kg-1) sample of Fadrozole (Afonso et al. 
1999) to inhibit aromatase to the same 
levels as the Letrozole at 2.5 mg AI kg-1 
which suggest that differences in 
concentration of the compounds due to 
the anti-aromatase effect of Letrozole is 
very potent (Séralini and Moslemi, 
2001; Sun et al., 2010).  
     Our results indicate that groups 
injected with letrozole contain potent 
component that can suppress activity of 
aromatase enzyme (Sioufi et al., 1997; 
Haynes et al., 2003). 
      Our results showed that serum 17α-
20β-P levels significantly increased at 6 
h after injection in the groups injected 
with letrozole, and in the group treated 
weekly with 2.5 mg kg-1 letrozole, 
serum E2 levels was declined up to 
528h after injection, and serum 17α-
20β-P levels significantly increased and 
remained high from 192 to 528 h after 
injection. But in the other two groups 
injected with letrozole, the increase of 
serum 17α-20β-P levels was transient. 
Similar results were obtained by 
Afonso et al (1999).  
       Letrozole had a global inhibitory 
effect on serum testosterone and 
estrogen in female trout. This is in 
accordance with the fact that in fish 
aromatase inhibitor plays a prominent 
role in the regulation of gametogenesis 
(Piferrer et al., 1994; Uchida et al. 
2004; Suzuki et al., 2004;). 
     In this experiment, letrozole effects 
on ovarian development were assessed 
by oocyte diameter and GSI. We found 
that multiple injection of letrozole 
resulted in inhibition/ delay of the 
gonadal development. This was 
confirmed by comparing the egg 
diameter and GSI in the group 
examined at the beginning of the 
experiment with the multiple injected 
group after 22 days. These two groups 
had similar egg diameters. Other 
investigations have reported that EDCS 
can specially affect the oocyte 
maturation stages. For example Afonso 
et al. (1999) reported that multiple 
injections of Fadrozole retarded the 
development of the oocytes in Coho 
salmon (O. kisutch). Bhatnagar et al. 
(1993) reported that letrozole inhibits 
the conversion of androstenedione to 
estrone in human and blocks estrogen-
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dependent uterine growth and negative 
feedback on FSH secretion that is 
responsible for gonadal growth. 
Estrogens are responsible for growth 
and oocyte maturation,  maturation and 
ovulation are also regulated by 
estrogens and progesterone (Peter and 
Yu, 1997; Lahnsteiner et al., 2006; 
Yelghi et al., 2012). It would be 
expected that multiple injection of 
letrozole would cause retardation in 
oocyte growth. Due to transitory effect 
of Letrozole on Serum E2 secretion in 
the other two groups the GSI and 
oocyte diameter had not been affected.  
      In conclusion, we showed that 
multiple injection of letrozole displays 
marked inhibitory effect on gonadal 
development and serum sex steroid in 
rainbow trout. Letrozole is a triazole 
derivative, and is a competitive and 
reversible aromatase inhibitor which is 
highly potent and selective for 
aromatase. This study showed that 
letrozole effects are dose and time-
depended dependent. The aromatase 
inhibitor technique, might also be a 
promising method for controlling the 
onset of puberty in aquaculture species. 
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